Nom du produit:2-Aminoethyl-mono-amide-DOTA-tris(tBu ester)

IUPAC Name:tert-butyl 2-(4-{[(2-aminoethyl)carbamoyl]methyl}-7,10-bis[2-(tert-butoxy)-2-oxoethyl]-1,4,7,10-tetraazacyclododecan-1-yl)acetate

CAS:173308-19-5
Formule moléculaire:C30H58N6O7
Pureté:95%+
Numéro de catalogue:CM339156
Poids moléculaire:614.83

Unité d'emballage Stock disponible Prix($) Quantité
CM339156-25mg in stock řƏ
CM339156-50mg in stock ƩĜŁ
CM339156-100mg in stock ƩǎŽ
CM339156-250mg in stock ǭǭƩ
CM339156-1g in stock ƩĜĨĜ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:173308-19-5
Formule moléculaire:C30H58N6O7
Point de fusion:-
Code SMILES:O=C(OC(C)(C)C)CN1CCN(CC(OC(C)(C)C)=O)CCN(CC(NCCN)=O)CCN(CC(OC(C)(C)C)=O)CC1
Densité:
Numéro de catalogue:CM339156
Poids moléculaire:614.83
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

ADC-Linkers
The ADC linker is one of the three main components of antibody drug conjugates (ADCs), linking the antibody to the effective drug (payload) through chemical bonds. ADC linkers play a key role in determining the overall success of antibody drug conjugates. One of the major challenges in developing safe and effective ADC drugs is to assemble an ideal chemical linker between the cytotoxic payload and the mAb. Well-designed ADC linkers can help the selective delivery of antibodies at the tumor site and the accurate release of cytotoxic drugs.
Non-cleavable linkers
Noncleavable linkers consist of stable bonds that resist proteolytic degradation and provide higher stability than the cleavable linkers.
Amine
Amino